Asia Pacific Endoscopy Procedures Market

Historic Data: 2020-2021   |   Base Year: 2022   |    Forecast Period: 2023-2030

Analysis -By Procedures [Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM), Endoscopic Ultrasound (EUS), Interventional Pulmonology and Laparoscopy, Arthroscopy and Bronchoscopy, Colonoscopy and Colposcopy, Proctoscopy and Thoracoscopy, and Others], Offering [Endoscopes, ERCP Accessories, Head positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound (EUS) Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation tubing systems, Probes, Hemostasis Clip, Polyp Traps, Single-Use Valves , Trocar sleeves and Tissue Scissors and Cutters, Retrieval Devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights, etc.)], Product Type (Disposable and Reusable), and End User (Hospitals and Clinics, Ambulatory Surgical Centres, Diagnostic Laboratories, and Others)


No. of Pages: 165  |  Report Code: BMIRE00029152  |  Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
Asia Pacific Endoscopy Procedures Market

The Asia Pacific endoscopy procedures market is expected to grow from US$ 8,044.94 million in 2022 to US$ 14,103.00 million by 2030. It is estimated to grow at a CAGR of 7.3% from 2022 to 2030.   

Increasing Prevalence of Cancer Fuel to the Asia Pacific Endoscopy Procedures Market

Cancer is a major public health problem and leading cause of death across the world. Increasing gastrointestinal disorders and cancer cases also accelerate the endoscope adoption and market growth. Colorectal cancer is increasingly affecting populations in Asian countries. According to the International Agency for Research on Cancer & GLOBOCON, ~1 million new colorectal cancer cases were reported in Asia in 2020. Japan, China, Malaysia, Singapore, and South Korea witnessed high prevalence rates compared to other countries in the region. Additionally, Asia had the highest global percentages of incident (51.8%) and death (52.4%) colorectal cancer cases (all age groups and genders) per 100,000 people in 2018. Furthermore, this disease has been increasingly prevalent throughout Asia, with certain regional and geographic variations. Westernized food, an aging population, smoking, physical inactivity, and other risk factors are the major causes of this increase in CRC. Furthermore, the most recent estimates from GLOBOCAN for 2020 show that only 60% (1,315,136) of newly diagnosed cases of lung cancer and 62% (1,112,517) of all lung cancer-related fatalities occurred in Asia. Also, gastric cancer (GC) is considered one of the most dangerous cancers in the world; in 2020, there were over one billion new cases and 783,000 deaths from GC. Asian nations have a notably high incidence of GC, and Eastern Asia has recently recorded more than 60% of GC cases. Compared to populations in Western nations, stomach cancer has historically impacted East Asian populations disproportionately. In Japan, stomach cancer is the most frequent cancer among men, and half of all occurrences of the disease occur in China. Inflammatory bowel disease (IBD) is a term for two conditions – ulcerative colitis (UC) and Crohn’s disease (CD). Moreover, in the last few years, cases of IBD have increased worldwide due to a sedentary lifestyle, changing dietary habits, stress, and poor nutritional choices. The intake of processed foods and trans-fats has drastically increased globally. Also, Asia saw a rise in IBD cases from 763,544 in 1990 to 1,992,221.5 in 2019. Asia had the highest overall incidence and prevalence of IBD among the four continents in 2019. Also, according to the IBS Global Impact Report, in 2016, the estimated prevalence of irritable bowel syndrome in Asia was 9.6%. Further, chronic inflammation and reduced immunosurveillance caused by IBD may contribute to the development of gastric cancer. Thus, the rising burden of cancer in the region indicates the high requirement for endoscopic devices, thus driving the market growth.

Asia Pacific Endoscopy Procedures Market Overview

The endoscopic procedures market in Asia Pacific is segmented into India, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. This region accounted for over 26.05% of the global endoscopy procedure market owing to a large population base in countries such as China and India. The increasing focus of market players on introducing new products or therapies is the major factor promoting the market growth.

Asia Pacific Endoscopy Procedures Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Endoscopy Procedures Market Segmentation

The Asia Pacific endoscopy procedures market is segmented into procedure, offering, product type, and end user.

Based on procedure, the Asia Pacific endoscopy procedures market is segmented into endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology and laparoscopy, arthroscopy and bronchoscopy, colonoscopy and colposcopy, proctoscopy and thoracoscopy, and others. The arthroscopy and bronchoscopy segment held the largest share of the Asia Pacific endoscopy procedures market in 2022.

Based on offering, the Asia Pacific endoscopy procedures market is segmented endoscopes, ERCP accessories, visualization system, head positioner and endotherapy injection needles, sampling device and device clip and electrosurgical knife, endoscopic ultrasound guided devices, guidewire, forceps, snare, irrigation/insufflation tubing systems, probes, hemostats clip, polyps’ traps, single-use valves, trocar sleeves and tissue scissors and cutters, retrieval devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights etc.). The endoscopes segment held the largest share of the Asia Pacific endoscopy procedures market in 2022.

Based on product type, the Asia Pacific endoscopy procedures market is bifurcated into disposable and reusable. The reusable segment held a larger share of the Asia Pacific endoscopy procedures market in 2022.

Based on end user, the Asia Pacific endoscopy procedures market is segmented into hospitals and clinics, ambulatory surgical centres, diagnostic laboratories, and others. The hospitals and clinics segment held the largest share of the Asia Pacific endoscopy procedures market in 2022.

Based on country, the Asia Pacific endoscopy procedures market is segmented into the India, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific endoscopy procedures market in 2022.   

Stryker Corp, FUJIFILM Holdings Corp, Merit Medical Systems Inc, Smith & Nephew Plc, Arthrex Inc, Steris Plc, Conmed Corp, Olympus Corp, Boston Scientific Corp, and Cook Medical LLC, are some of the leading companies operating in the Asia Pacific endoscopy procedures market.    


Asia Pacific Endoscopy Procedures Strategic Insights

Strategic insights for the Asia Pacific Endoscopy Procedures provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-endoscopy-procedures-market-strategic-framework.webp
Get more information on this report

Asia Pacific Endoscopy Procedures Report Scope

Report Attribute Details
Market size in 2022 US$ 8,044.94 Million
Market Size by 2030 US$ 14,103.00 Million
Global CAGR (2022 - 2030) 7.3%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Procedures
  • Endoscopic Retrograde Cholangiopancreatography
  • Endoscopic Submucosal Dissection
  • Peroral Endoscopic Myotomy
  • Endoscopic Ultrasound
  • Interventional Pulmonology and Laparoscopy
  • Arthroscopy and Bronchoscopy
  • Colonoscopy and Colposcopy
  • Proctoscopy and Thoracoscopy
By Offering
  • Endoscopes
  • ERCP Accessories
  • Head positioner and Endotherapy Injection Needles
  • Sampling Device and Device Clip and Electrosurgical Knife
  • Endoscopic Ultrasound Guided Devices
  • Guidewire
  • Forceps
  • Snare
  • Irrigation/Insufflation tubing systems
  • Probes
  • Hemostasis Clip
  • Polyp Traps
  • Single-Use Valves
  • Trocar sleeves and Tissue Scissors and Cutters
  • Retrieval Devices
By Product Type
  • Disposable
  • Reusable
By End User
  • Hospitals and Clinics
  • Ambulatory Surgical Centres
  • Diagnostic Laboratories
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Stryker Corp
  • FUJIFILM Holdings Corp
  • Merit Medical Systems Inc
  • Smith & Nephew Plc
  • Arthrex Inc
  • Steris Plc
  • Conmed Corp
  • Olympus Corp
  • Boston Scientific Corp
  • Cook Medical LLC
Get more information on this report

Asia Pacific Endoscopy Procedures Regional Insights

The geographic scope of the Asia Pacific Endoscopy Procedures refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

geography/asia-pacific-endoscopy-procedures-market-geography.webp
Get more information on this report

The List of Companies - Asia Pacific Endoscopy Procedures Market

  • Stryker Corp
  • FUJIFILM Holdings Corp
  • Merit Medical Systems Inc
  • Smith & Nephew Plc
  • Arthrex Inc
  • Steris Plc
  • Conmed Corp
  • Olympus Corp
  • Boston Scientific Corp
  • Cook Medical LLC
Frequently Asked Questions
How big is the Asia Pacific Endoscopy Procedures Market?

The Asia Pacific Endoscopy Procedures Market is valued at US$ 8,044.94 Million in 2022, it is projected to reach US$ 14,103.00 Million by 2030.

What is the CAGR for Asia Pacific Endoscopy Procedures Market by (2022 - 2030)?

As per our report Asia Pacific Endoscopy Procedures Market, the market size is valued at US$ 8,044.94 Million in 2022, projecting it to reach US$ 14,103.00 Million by 2030. This translates to a CAGR of approximately 7.3% during the forecast period.

What segments are covered in this report?

The Asia Pacific Endoscopy Procedures Market report typically cover these key segments-

  • Procedures (Endoscopic Retrograde Cholangiopancreatography, Endoscopic Submucosal Dissection, Peroral Endoscopic Myotomy, Endoscopic Ultrasound, Interventional Pulmonology and Laparoscopy, Arthroscopy and Bronchoscopy, Colonoscopy and Colposcopy, Proctoscopy and Thoracoscopy)
  • Offering (Endoscopes, ERCP Accessories, Head positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation tubing systems, Probes, Hemostasis Clip, Polyp Traps, Single-Use Valves, Trocar sleeves and Tissue Scissors and Cutters, Retrieval Devices)
  • Product Type (Disposable, Reusable)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Endoscopy Procedures Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Endoscopy Procedures Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Endoscopy Procedures Market?

    The Asia Pacific Endoscopy Procedures Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Stryker Corp
  • FUJIFILM Holdings Corp
  • Merit Medical Systems Inc
  • Smith & Nephew Plc
  • Arthrex Inc
  • Steris Plc
  • Conmed Corp
  • Olympus Corp
  • Boston Scientific Corp
  • Cook Medical LLC
  • Who should buy this report?

    The Asia Pacific Endoscopy Procedures Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Endoscopy Procedures Market value chain can benefit from the information contained in a comprehensive market report.